Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Arbutus Biopharma Corp (ABUS) SEC filings
Arbutus Biopharma Corp (ABUS) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported ABUS revenue for 2025-12-31 was $14.1M. Net income was -$33.5M. Revenue was up 128.2% from 2024-12-31 to 2025-12-31. ABUS currently screens at market cap $883.0M. The ABUS filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Arbutus Biopharma Corp said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsEvent insights for ABUS — what management said, what changed, and why it matters.
Recent filings
ABUS SEC filings FAQ
What is the latest ABUS SEC filing?
The latest cached Arbutus Biopharma Corp (ABUS) filing on this page is 8-K · Aug 21, 2026. Filings: https://lician.com/sec/abus
What is the latest ABUS filing accession number?
The latest cached Arbutus Biopharma Corp (ABUS) accession number on this page is 0001104659-26-099390. Filing: https://lician.com/sec/abus/0001104659-26-099390
Which item codes are on the latest ABUS filing?
Cached item codes on the latest Arbutus Biopharma Corp (ABUS) 8-K are 8.01, 9.01.
How many ABUS SEC filings are listed on this page?
This page lists 4 cached Arbutus Biopharma Corp (ABUS) SEC filings. Filings: https://lician.com/sec/abus
What events are listed on the ABUS SEC page?
Cached event headlines on this Arbutus Biopharma Corp (ABUS) SEC page: "ABUS earnings". Events: https://lician.com/sec/abus
What are ABUS's latest revenue and net income?
Latest cached Arbutus Biopharma Corp (ABUS) revenue for Dec 31, 2025 was $14.1M. Net income was -$33.5M. Statements: https://lician.com/financials/abus